Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.390
+0.060 (1.39%)
Feb 11, 2025, 2:05 PM EST - Market open
ZYBT Employees
Zhengye Biotechnology Holding had 286 employees as of December 31, 2023. The number of employees decreased by 8 or -2.72% compared to the previous year.
Employees
286
Change (1Y)
-8
Growth (1Y)
-2.72%
Revenue / Employee
$91,298
Profits / Employee
$9,761
Market Cap
207.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 286 | -8 | -2.72% |
| Dec 31, 2022 | 294 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ZYBT News
- 4 weeks ago - Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
- 4 weeks ago - U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline - Seeking Alpha
- 4 weeks ago - Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewsWire
- 5 weeks ago - Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology's Growth Slows As It Seeks U.S. IPO - Seeking Alpha
- 1 year ago - Chinese animal health company Zhengye Biotechnology Holding files for a $20 million US IPO - Renaissance Capital
- 1 year ago - Zhengye Biotechnology IPO Registration Document (F-1) - SEC